Methodology

Wing Tech combines advanced analytical methodologies with deep expertise in life sciences technologies, healthcare systems, and global markets to support evidence-based strategic decision-making. The firm’s core competencies encompass systems analysis, quantitative modeling, health-economic evaluation, risk assessment, and strategic decision support across medical devices and diagnostics, biotechnology, digital health, health services, and pharmaceuticals.

Drawing on established quantitative and qualitative research methods, Wing Tech integrates clinical, technical, economic, and market evidence into comprehensive analytical frameworks. These analyses provide a rigorous foundation for evaluating opportunities, assessing risks, demonstrating value, and informing strategic decisions throughout the innovation and commercialization lifecycle.

Lifecycle Research Support

Medical technologies and therapies require different types of evidence and analytical support as they progress through development, clinical evaluation, commercialization, and market adoption. Wing Tech provides tailored research and strategic analysis to address the evolving evidence needs of innovators throughout the health technology lifecycle, including the following.

Due Diligence

Wing Tech applies its extensive knowledge of medical technologies, healthcare systems, and market access environments to evaluate emerging concepts and early-stage products. The firm’s due diligence assessments focus on clinical and economic value, reimbursement potential, and factors influencing commercial viability.

Value Assessment

Wing Tech conducts rigorous health-economic evaluations of innovative diagnostic and therapeutic technologies, helping clients assess, substantiate, and communicate their products’ value propositions throughout the technology lifecycle. The firm combines advanced health-economic and decision-analytic modeling capabilities with extensive knowledge of clinical applications, healthcare systems, and medical technology innovation. Working closely with clinical investigators and research partners, Wing Tech develops evidence-based analyses that meet rigorous scientific standards and inform clinical, economic, and strategic decision-making.

Health Economics Core Lab

Wing Tech serves as a health economics core laboratory for clinical studies, providing specialized research support to clinical investigators and study sponsors. Services include the design and implementation of economic data collection protocols and the analysis of healthcare resource utilization, costs, reimbursement data, and patient-reported outcomes, including quality of life. These activities support the generation of robust economic evidence alongside clinical investigations and provide essential inputs for subsequent health-economic evaluations.

Value Communication

Wing Tech helps translate complex analytical findings into clear, scientifically grounded evidence to inform clinical, economic, and strategic decision-making. The firm has an extensive track record of publishing health-economic research in peer-reviewed journals and presenting findings at international clinical and health economics conferences. Wing Tech also develops interactive analytical tools and evidence-based communication materials to support the evaluation and communication of the value propositions of innovative medical technologies.

Strategic Applications

Wing Tech develops quantitative models and analytical frameworks to assess the clinical benefits, economic value, and commercial potential of innovative healthcare technologies and products. These analyses provide a rigorous foundation for strategic decision-making across the technology lifecycle, from early opportunity assessment and product development to commercialization, market access, and portfolio management.

Applications of Wing Tech’s research and analytical capabilities include:

Concept due diligence
Early-stage opportunity assessment
Investment evaluation and decision support
Strategic resource allocation and prioritization
Product development planning and reassessment
Go/no-go decisions
Engineering, clinical, and market research strategy
Regulatory and reimbursement strategy
Clinical trial design and planning
Product launch and commercialization strategy
Licensing and partnership evaluations
Product pricing and economic value assessment
Portfolio evaluation and management